Steris | STE - Des Atouts





Des Atouts Changement Date
3M USD 34.92B 512M 2026-06
Accuray USD 448.01M 8.81M 2025-12
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
CONMED USD 2.3B 14.64M 2026-06
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.46B 178M 2026-06
Ecolab USD 29.93B 4.89B 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Fortive USD 11.62B 30.9M 2026-06
Getinge SEK 57.37B 6.55B 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Idexx Laboratories USD 3.44B 56.84M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 201.06B 167M 2026-06
Olympus JPY 1.53T 10.69B 2026-06
Orthofix International USD 873.02M 13.58M 2026-06
Owens Minor USD 2.11B 308.57M 2026-06
ResMed USD 8.97B 181.66M 2026-06
Steris USD 10.74B 1.1M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06